Related references
Note: Only part of the references are listed.Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients
Lluis Masana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
COVID-19, ACE2, and the cardiovascular consequences
Andrew M. South et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Patients with diabetes are at higher risk for severe illness from COVID-19
G. Targher et al.
DIABETES & METABOLISM (2020)
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
A. J. Scheen et al.
DIABETES & METABOLISM (2020)
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target
Mohamed Abu-Farha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Hypolipidemia is associated with the severity of COVID-19
Xiuqi Wei et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis
Marco Zuin et al.
JOURNAL OF INFECTION (2020)
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zhaohai Zheng et al.
JOURNAL OF INFECTION (2020)
Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis
Wenjie Tian et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
Michael G. Argenziano et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
Junli Fan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Potential Effects of Coronaviruses on the Cardiovascular System A Review
Mohammad Madjid et al.
JAMA CARDIOLOGY (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Considerations for Statin Therapy in Patients with COVID-19
Simin Dashti-Khavidaki et al.
PHARMACOTHERAPY (2020)
Meta-analysis of Effect of Statins in Patients with COVID-19
Chia Siang Kow et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Metformin and COVID-19: From cellular mechanisms to reduced mortality
A. J. Scheen
DIABETES & METABOLISM (2020)
Statins: Could an old friend help in the fight against COVID-19?
Raul R. Rodrigues-Diez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19
Xiao-Jin Zhang et al.
CELL METABOLISM (2020)
Teaching Old Drugs New Tricks: Statins for COVID-19?
David C. Fajgenbaum et al.
CELL METABOLISM (2020)
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
Giacomo Grasselli et al.
JAMA INTERNAL MEDICINE (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Cholesterol in Relation to COVID-19: Should We Care about It?
Dina Radenkovic et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients
Lori B. Daniels et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Statin Treatment of COVID-19
David S. Fedson
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19
Abbas Soleimani et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents
Anton De Spiegeleer et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Matthias P. Nagele et al.
ATHEROSCLEROSIS (2020)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga et al.
NATURE REVIEWS CARDIOLOGY (2020)
Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study
Huadong Yan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Statistical and clinical significances: Are they equivalent?
L. Monnier et al.
DIABETES & METABOLISM (2020)
Antiviral effects of statins
Armita M. Gorabi et al.
PROGRESS IN LIPID RESEARCH (2020)
Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action
Rosario Rossi et al.
INTERNAL AND EMERGENCY MEDICINE (2020)
Coronavirus and Cardiometabolic Syndrome JACC Focus Seminar
Jeffrey Mechanick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Repurposing existing drugs for COVID-19: an endocrinology perspective
Flavio A. Cadegiani
BMC ENDOCRINE DISORDERS (2020)
Statin use is associated with lower disease severity in COVID-19 infection
Wilnard Y. T. Tan et al.
SCIENTIFIC REPORTS (2020)
Statin Use and In-Hospital Mortality in Patients With Diabetes Mellitus and COVID-19
Omar Saeed et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study
Sophia L. Song et al.
PATHOGENS (2020)
Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia
Sandeep Krishnan et al.
JOURNAL OF CLINICAL ANESTHESIA (2020)
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
Shiva Ganjali et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study
Jawad Haider Butt et al.
BMJ OPEN (2020)
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK
Zohaib Iqbal et al.
ATHEROSCLEROSIS (2020)
Statins and SARS-CoV-2 disease: Current concepts and possible benefits
Madhu Mary Minz et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: Reasoning about connections
Giampaolo Minetti
MEDICAL HYPOTHESES (2020)
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection
Timotius Ivan Hariyanto et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Mortality Risk Factors among Hospitalized COVID-19 Patients in a Major Referral Center in Iran
Nasser Malekpour Alamdari et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study
Guillermo Rodriguez-Nava et al.
CRITICAL CARE (2020)
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
Ray Subir et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Zeljko Reiner et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
Statins and outcomes of hospitalized patients with laboratory-confirmed 2017-2018 influenza
Alaa Atamna et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis
B. Pertzov et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
Carolyn S. Calfee et al.
LANCET RESPIRATORY MEDICINE (2018)
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study
Pratik Sinha et al.
INTENSIVE CARE MEDICINE (2018)
Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis
Bo Xiong et al.
RESPIROLOGY (2016)
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Shu Yuan
MBIO (2015)
Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
Marios Margaritis et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies
You-Dong Wan et al.
CRITICAL CARE (2014)
Treating influenza with statins and other immunomodulatory agents
David S. Fedson
ANTIVIRAL RESEARCH (2013)
Statins as Antithrombotic Drugs
Francesco Violi et al.
CIRCULATION (2013)
Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study
Meredith L. Vandermeer et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins
Floyd J. Frost et al.
CHEST (2007)
Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
U Schönbeck et al.
CIRCULATION (2004)
Share Paper
